IPSC Daphne Quimi buys $8K worth of shares
Sep 16, 2024, 9:33 PM
-1.96%
What does IPSC do
Century Therapeutics, based in Philadelphia, develops off-the-shelf allogeneic cell therapies for cancer, employing 152 staff since its IPO on June 17, 2021. Its product candidates target various malignancies, including CNTY-101 and CNTY-102 for B-cell lymphoma.
Daphne Quimi bought 5,000 shares of IPSC on 12 September at $1.53 per share, worth a total of $8K. They now own 5,000 IPSC shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.